References
- Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis. 2019;14:139. doi: 10.118.6/s13023-019-1255-6
- El-Rifai N, Lumbroso S, Cartigny M, Weill J, Sultan C, Gottrand F. Infant cholestasis in McCune-Albright syndrome. Acta Paediatr. 2004;93:141. doi: 10.1080/08035250310007880
- Claeys KG, Zuchner S, Kennerson M, Berciano J, García A, Verhoeven K, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain. 2009;132:1741–52. doi: 10.1093/brain/awp115
- Yahyaoui R, Blasco-Alonso J, Benito C, Rodríguez-García E, Andrade F, Aldámiz-Echevarría L, et al. A new metabolic disorder in human cationic amino acid transporter-2 that mimics arginase 1 deficiency in newborn screening. J Inherit Metab Dis. 2019;42:407–13. doi: 10.1002/jimd.12063